Stocks and Investing Stocks and Investing
Fri, August 14, 2020
Thu, August 13, 2020
Wed, August 12, 2020
Tue, August 11, 2020
Mon, August 10, 2020

Vikram Purohit Maintained (TBPH) at Hold with Decreased Target to $29 on, Aug 10th, 2020


Published on 2024-10-27 12:00:26 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Hold with Decreased Target from $30 to $29 on, Aug 10th, 2020.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $29 on, Tuesday, July 7th, 2020
  • Marc Frahm of "Cowen & Co." Initiated at Buy and Held Target at $42 on, Wednesday, May 13th, 2020